Aethlon Medical (AEMD) Stock Price, Quote & News

Company Profile

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Industry: Medical Devices

Sector: Healthcare

Phone: 619 941 0360

Fax: 619 941 0361

Website: www.aethlonmedical.com

Address:

11555 Sorrento Valley Road, Suite 203, San Diego, United States

FCGEnterprises Nov. 14 at 11:53 AM

$AEMD let’s have a blessed day

0 · Reply

illumantistocks Nov. 13 at 11:40 PM

$AEMD she couod run up here before end of day into tomorrow folks

0 · Reply

_SquidGains_ Nov. 13 at 11:32 PM

$ETHZ $DHAI $AEMD $PSIG watching

0 · Reply

illumantistocks Nov. 13 at 10:15 PM

$AEMD Tomorrow premarket we could we well over 5 by start and on our way to 6 mid-day folks. mark this post baby.

0 · Reply

illumantistocks Nov. 13 at 9:34 PM

$AEMD I am in. I think this is just the start folks. Market was Red today tomorrow she rides higher. Not a ton but she will go a buck or two.

0 · Reply

Ripafterthedip Nov. 13 at 7:46 PM

$AEMD lets get a new 52wk high

0 · Reply

Bazzzigar Nov. 13 at 1:20 PM

$AEMD

0 · Reply

Gettinsome Nov. 13 at 12:44 AM

$AEMD so what are we thinking will happen next? After hours is cool

0 · Reply

d_risk Nov. 12 at 10:15 PM

$AEMD - AETHLON MEDICAL INC - 10Q - Updated Risk Factors AEMD adds risk that underfunded FDA or regulators could delay product development and approvals, potentially disrupting business; otherwise, no material changes to prior risk disclosures. #MedicalDevices #BusinessDisruption #ProductDevelopment #FDAApproval #RegulatoryRisk 🟢 Added 🟠 Removed https://d-risk.ai/AEMD/10-Q/2025-11-12

0 · Reply

Starrynight1678 Nov. 12 at 9:38 PM

$AEMD

0 · Reply

Aethlon Medical, Inc. (AEMD) Q2 2026 Earnings Call Transcript

Nov 12, 2025, 4:15 PM EST - 2 days ago

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Nov 7, 2025, 8:01 AM EST - 7 days ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Oct 7, 2025, 8:01 AM EDT - 5 weeks ago

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

Sep 4, 2025, 9:15 AM EDT - 2 months ago

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Sep 3, 2025, 8:01 AM EDT - 2 months ago

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Aug 13, 2025, 8:01 PM EDT - 3 months ago

Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript

Aug 13, 2025, 4:15 PM EDT - 3 months ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aug 5, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Jul 15, 2025, 8:01 AM EDT - 4 months ago

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Jun 26, 2025, 7:35 PM EDT - 5 months ago

Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript

Jun 26, 2025, 4:15 PM EDT - 5 months ago

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Jun 20, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Jun 18, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Jun 9, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

May 14, 2025, 8:01 AM EDT - 6 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Mar 10, 2025, 8:01 AM EDT - 8 months ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Feb 13, 2025, 8:01 AM EST - 9 months ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 12, 2025, 8:11 PM EST - 9 months ago

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Feb 12, 2025, 4:15 PM EST - 9 months ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 5, 2025, 8:01 AM EST - 10 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Jan 29, 2025, 8:01 AM EST - 10 months ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Dec 20, 2024, 8:01 AM EST - 11 months ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Nov 14, 2024, 8:00 AM EST - 1 year ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 13, 2024, 7:58 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

Innovative Medical Technology Advances with First Patient Enrollments

Nov 11, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 6, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Oct 8, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 8:01 AM EDT - 1 year ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 17, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Innovation Driving Cancer's Solid Tumors Market

Sep 16, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 13, 2024, 8:35 AM EDT - 1 year ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aug 27, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 14, 2024, 6:45 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 12, 2024, 9:01 AM EDT - 1 year ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 6, 2024, 9:12 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Jun 27, 2024, 6:37 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 21, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 20, 2024, 7:00 AM EDT - 1 year ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 18, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 7, 2024, 8:00 AM EDT - 1 year ago

The Hunt for Virus Treatments Continues Post Covid-19

Jun 3, 2024, 9:05 AM EDT - 1 year ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Jun 3, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

FCGEnterprises Nov. 14 at 11:53 AM

$AEMD let’s have a blessed day

0 · Reply

illumantistocks Nov. 13 at 11:40 PM

$AEMD she couod run up here before end of day into tomorrow folks

0 · Reply

_SquidGains_ Nov. 13 at 11:32 PM

$ETHZ $DHAI $AEMD $PSIG watching

0 · Reply

illumantistocks Nov. 13 at 10:15 PM

$AEMD Tomorrow premarket we could we well over 5 by start and on our way to 6 mid-day folks. mark this post baby.

0 · Reply

illumantistocks Nov. 13 at 9:34 PM

$AEMD I am in. I think this is just the start folks. Market was Red today tomorrow she rides higher. Not a ton but she will go a buck or two.

0 · Reply

Ripafterthedip Nov. 13 at 7:46 PM

$AEMD lets get a new 52wk high

0 · Reply

Bazzzigar Nov. 13 at 1:20 PM

$AEMD

0 · Reply

Gettinsome Nov. 13 at 12:44 AM

$AEMD so what are we thinking will happen next? After hours is cool

0 · Reply

d_risk Nov. 12 at 10:15 PM

0 · Reply

Starrynight1678 Nov. 12 at 9:38 PM

$AEMD

0 · Reply

AlbertaSwingTrader Nov. 12 at 9:37 PM

$AEMD Will this fly on earnings once volume returns at the open? Super low float…

0 · Reply

JimBull Nov. 12 at 9:20 PM

$AEMD float less than 1 M and earning news:

0 · Reply

The_Baba_Yaga Nov. 12 at 6:53 PM

$AEMD Deifnitley WW on this one

0 · Reply

makedatbread88 Nov. 12 at 6:39 PM

$AEMD 655k float now after reverse split Earnings after hours Very under the radar any positive news sends it Great spot to add here

0 · Reply

Dulge_Gappana Nov. 12 at 2:57 PM

$CTSO wow are they selling same like magic tube like $AEMD

0 · Reply

makedatbread88 Nov. 10 at 3:03 PM

$AEMD i like this ticker a lot. Super low floater and many catalysts starting with earnings Wednesday 655k float, earnings Wednesday, and there Aethlon Hemopurifier device is the real deal Target $10+

0 · Reply

OPTIONTURD Nov. 6 at 6:07 PM

$AEMD Regained compliance with NASDAQ price qualifications.....:-)

0 · Reply

Trade4Keeps Nov. 3 at 8:34 PM

Looks like folks are still playing these low float reverse splits here and there $ENVB 500k shares $ADTX 500k shares $AEMD 700k share $CLIK 1mil shares $RAYA 900k shares

0 · Reply

Hedgieguy75 Oct. 31 at 2:12 PM

$AEMD hold on ..we've seen this before .. drop it early and run it !

0 · Reply

STKH Oct. 30 at 7:12 PM

$XLO $ADVB 0.53 >>>c 0.6 $NUWE may 4.3------------5 $AEMD 5.5 $SMX may u

0 · Reply

eastman71 Oct. 29 at 10:58 PM

$AEMD Tell me about AEMD!

0 · Reply

eastman71 Oct. 29 at 9:38 PM

$AEMD Please God, let us see a rise here like in CMBM

0 · Reply

Market Cap	1.09M
Revenue (ttm)	0.00
Net Income (ttm)	-13.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	30,800
Avg Vol	62,843
Day's Range	N/A - N/A
Shares Out	260,000.00
Stochastic %K	59%
Beta	1.83
Analysts	Hold
Price Target	$9.75